Jasmine Gao has been engaged in clinical ophthalmology, scientific research on inherited eye diseases, medical and clinical development of ophthalmology drugs for more than 16 years. Before joining Frontera, Jasmine served as the Head of the Clinical Development Department at Affamed, responsible for developing strategies for ophthalmology, neuroscience and psychiatric pipelines, organizing and implementing clinical development, including the clinical development of nearly ten ophthalmology products in the United States or Greater China. As the project leader, Jasmine led the team to obtain the first approval of phase 3 clinical trial of an innovative drug for the treatment of dry age-related macular degeneration in China. Before that, Jasmine worked in Roche PD China as the first Medical Director of ophthalmology. Jasmine led and supported all the development plans and clinical trials of Roche’s global ophthalmology pipelines in China, built a physician team of ophthalmology from 0 to 1, and was the Project Leader of Roche’s first ophthalmology product in China. Jasmine and her team covered the Medical Monitoring related work in the Asia-Pacific regions such as Japan, South Korea and Australia.

Jasmine was trained in medicine and completed a medical Master Degree in ophthalmology in China Medical University, and subsequently completed a Ph.D. in Advanced Photonics Medicine at the Hamamatsu University School of Medicine, Japan.